UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017407
Receipt number R000020193
Scientific Title The effectiveness study of psychotropic-induced side effect monitoring by community pharmacists
Date of disclosure of the study information 2015/05/07
Last modified on 2017/02/10 02:22:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effectiveness study of psychotropic-induced side effect monitoring by community pharmacists

Acronym

The effectiveness study of psychotropic-induced side effect monitoring by community pharmacists

Scientific Title

The effectiveness study of psychotropic-induced side effect monitoring by community pharmacists

Scientific Title:Acronym

The effectiveness study of psychotropic-induced side effect monitoring by community pharmacists

Region

Japan


Condition

Condition

Mental illness

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate effectiveness of psychotropic-induced side effect monitoring conducted by community pharmacists

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1) Number of times of prescription change and/or dose adjustment
2) Change of psychotropic dosage

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Monitoring of psychotropic-induced side effects conducted by community pharmacists

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with mental illness received prescriptions in study community pharmacies

Key exclusion criteria

none

Target sample size

75


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ataru Inagaki

Organization

Aoyama Gakuin University

Division name

Health Administration Center

Zip code


Address

4-4-25 Shibuya, Shibuya, Tokyo, Japan 150-836

TEL

03-3409-7896

Email

ina-chun@hotmail.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ataru Inagaki

Organization

Aoyama Gakuin University

Division name

Health Administration Center

Zip code


Address

4-4-25 Shibuya, Shibuya, Tokyo, Japan 150-836

TEL

03-3409-7896

Homepage URL


Email

ina-chun@hotmail.co.jp


Sponsor or person

Institute

Aoyama Gakuin University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Toho University Faculty of Pharmaceutical Science

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ひもろぎ心のクリニック(東京都),茜薬局(東京都),萩原薬局(東京都),公益財団法人住吉偕成会住吉病院(山梨県),池川薬局(山梨県)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 07 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://mhlw-grants.niph.go.jp/niph/search/NIDD02.do?resrchNum=201523012A

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 05 Month 16 Day

Last follow-up date

2015 Year 10 Month 31 Day

Date of closure to data entry

2016 Year 02 Month 15 Day

Date trial data considered complete

2016 Year 02 Month 29 Day

Date analysis concluded

2016 Year 03 Month 15 Day


Other

Other related information



Management information

Registered date

2015 Year 05 Month 03 Day

Last modified on

2017 Year 02 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020193